Cross Country Healthcare (CCRN) Misses Q2 EPS by 4c, Q3 Guidance Light
Cross Country Healthcare (NASDAQ: CCRN) reported Q2 EPS of ($0.05), $0.04 worse than the analyst estimate ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
